In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CardioMind: Big Solutions to Small Problems

Executive Summary

CardioMind is one of a small group of cardiovascular device start-ups who are finding surprising success in drug-eluting stents, a category dominated by big companies, by finding clinical niches that the big companies haven't been able to tap into.
Advertisement

Related Content

Next-Generation Coronary Stent Start-Ups: Making a Difference in a Mature Market
The Future of Drug-Eluting Stents Part I: Novel Next-Generation Designs
Xtent and the Next DES Boom
Xtent and the Next DES Boom
Industry Perspective - The Medtech Industry: A Look Back at 2006

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002658

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel